Literature DB >> 11161073

Parkinson's disease and anxiety.

K Walsh1, G Bennett.   

Abstract

There has been a recent surge of interest in the subject of anxiety in patients with Parkinson's disease. Up to 40% of patients with Parkinson's disease experience clinically significant anxiety. This anxiety may be a psychological reaction to the stress of the illness or may be related to the neurochemical changes of the disease itself. Antiparkinsonian drugs may have a role in the pathogenesis of the anxiety. The anxiety disorders in Parkinson's disease patients appear to be clustered in the panic disorder, phobic disorder, and generalised anxiety disorder areas. The degree of comorbidity between anxiety and depression in patients with Parkinson's disease is in excess of that found in patients without the disease and anxiety in combination with depression may represent a specific depressive subtype in Parkinson's disease. As yet, there is no trial evidence as to the treatment of anxiety in patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161073      PMCID: PMC1741918          DOI: 10.1136/pmj.77.904.89

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  45 in total

1.  Psychosocial problems of Parkinson patients: approaches to assessment and treatment.

Authors:  H Ellgring; S Seiler; U Nagel; B Perleth; T Gasser; W H Oertel
Journal:  Adv Neurol       Date:  1990

2.  Clinical and biochemical features of depression in Parkinson's disease.

Authors:  R Mayeux; Y Stern; J B Williams; L Cote; A Frantz; I Dyrenfurth
Journal:  Am J Psychiatry       Date:  1986-06       Impact factor: 18.112

3.  Plasma HVA and anxiety in patients with panic disorder.

Authors:  P P Roy-Byrne; T W Uhde; D A Sack; M Linnoila; R M Post
Journal:  Biol Psychiatry       Date:  1986-07       Impact factor: 13.382

4.  Parkinsonism induced by high doses of diazepam.

Authors:  B E Suranyi-Cadotte; J N Nestoros; N P Nair; S Lal; S Gauthier
Journal:  Biol Psychiatry       Date:  1985-04       Impact factor: 13.382

5.  Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus.

Authors:  R Cash; T Dennis; R L'Heureux; R Raisman; F Javoy-Agid; B Scatton
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

6.  Mood changes and "on-off" phenomena in Parkinson's disease.

Authors:  M A Menza; J Sage; E Marshall; R Cody; R Duvoisin
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

7.  Anxiety disorders in patients with Parkinson's disease.

Authors:  M B Stein; I J Heuser; J L Juncos; T W Uhde
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

8.  Depression in Parkinson's disease: a quantitative and qualitative analysis.

Authors:  A M Gotham; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

9.  Pergolide in late-stage Parkinson disease.

Authors:  A E Lang; N Quinn; S Brincat; C D Marsden; J D Parkes
Journal:  Ann Neurol       Date:  1982-09       Impact factor: 10.422

10.  Buspirone, Parkinson's disease, and the locus ceruleus.

Authors:  C L Ludwig; D R Weinberger; G Bruno; M Gillespie; K Bakker; P A LeWitt; T N Chase
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

View more
  39 in total

Review 1.  Neuropsychiatric non-motor aspects of Parkinson's disease.

Authors:  B R Thanvi; S K Munshi; N Vijaykumar; T C N Lo
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 2.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

3.  Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Authors:  Lori M Gorton; Marta G Vuckovic; Nina Vertelkina; Giselle M Petzinger; Michael W Jakowec; Ruth I Wood
Journal:  Behav Brain Res       Date:  2010-05-21       Impact factor: 3.332

4.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

5.  Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety.

Authors:  Anne S Berry; Robert L White; Daniella J Furman; Jenna R Naskolnakorn; Vyoma D Shah; Mark D'Esposito; William J Jagust
Journal:  J Neurosci       Date:  2019-02-08       Impact factor: 6.167

6.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

Review 7.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 8.  Psychiatric symptoms in Parkinson's disease.

Authors:  Frank Schneider; Astrid Althaus; Volker Backes; Richard Dodel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

9.  Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease.

Authors:  Neena S Sawant; S R Parkar; Heena R Merchant; Avinash A De Sousa; S H Ravat
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

Review 10.  Diagnosis and management of panic disorder in older patients.

Authors:  Alastair J Flint; Nadine Gagnon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.